Bundesamt für Gesundheit Sektion HTA www.bag.admin.ch/hta

Institute of Pharmaceutical Medicine ECPM www.ecpm.ch

Swiss Group for Clinical Cancer Research SAKK www.sakk.ch

Grüne Wohlen bei Bern http://www.grüne-wohlen.ch/

Midwife Lisanne Matter  http://www.hebamme-lisanne.ch/

Researchgate  https://www.researchgate.net/profile/Klazien_Matter-Walstra/?ev=hdr_xprf

Skiklub Wohlen http://www.skiklubwohlen-be.ch/

Solarkraftwerk Wohlen http://www.sokw.ch/

Sa

21

Dez

2019

Newest Publication

Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study.

Panje CM, Putora PM, Hundsberger T, Hottinger AF, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K.

Swiss Med Wkly. 2019 Dec 2;149:w20153. doi: 10.4414/smw.2019.20153. eCollection 2019 Dec 2.

Sa

31

Aug

2019

Segeln Kroatie

Do

08

Aug

2019

Rûzje Wyn

Our new sail yacht Rûzje Wyn, a Wauquiez Centaurion 40, 1987

mehr lesen

Do

25

Jul

2019

New publication

Cost-effectiveness of nivolumab in the treatment of head and neck cancer.

Hirschmann A, Lupatsch JE, Schwenkglenks M, Panje CM, Matter-Walstra K, Espeli V, Dedes KJ, Siano M; Swiss Group of Clinical Cancer Research (SAKK).

Oral Oncol. 2018 Dec;87:104-110. doi: 10.1016/j.oraloncology.2018.10.032. Epub 2018 Oct 30.

Mo

03

Jun

2019

Cuba Mai 2019

Fr

23

Nov

2018

New Publication

A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC).

Panje CM, Dedes KJ, Matter-Walstra K, Schwenkglenks M, Gautschi O, Siano M, Aebersold DM, Plasswilm L, Lupatsch JE; Swiss Group for Clinical Cancer Research (SAKK).

Radiother Oncol. 2018 Aug 10. pii: S0167-8140(18)33416-9. doi: 10.1016/j.radonc.2018.07.017. [Epub ahead of print]